Ardent Health Partners, Inc. (ARDT)
NYSE:ARDT
Want to see ARDT full AI Analyst Report?
Earnings Data
Report Date
Aug 19, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.25Last Year’s EPS
0.52Same Quarter Last Year
Moderate Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: solid top-line growth (+7% revenue), strong adjusted EBITDA improvement (+26%, or +15% excluding a one-time investment gain), meaningful margin expansion (110 bps), demonstrable cost and labor discipline (contract labor down >40%, SW&B per AA improvements), and healthy liquidity and leverage metrics. Management acknowledged near-term volume headwinds from weather and lighter flu, exchange-related revenue pressure (~$35M estimated headwind), higher professional fees and medical malpractice premium increases, and ongoing denial-management work. On balance, the positive execution against the IMPACT program, margin gains, cash/liquidity strength, and disciplined growth initiatives outweigh the noted challenges.Company Guidance
Revenue Growth
First quarter revenue of $1.6 billion, up 7% year-over-year.
Strong EBITDA and Margin Expansion
Adjusted EBITDA increased 26% year-over-year to $124 million; adjusted EBITDA margin expanded 110 basis points to 7.7%. Pre-NCI adjusted EBITDAR margin expanded 100 basis points to 11.5%. Excluding a $10.9 million pre-tax investment gain, adjusted EBITDA growth was 15%.
Volume and Service Line Performance
Adjusted admissions grew 2% (midpoint of 2026 guidance range of 1.5%–2.5%); total surgeries grew 1.2% y/y with outpatient surgery growth of 1.7%.
IMPACT Program Savings and Execution
IMPACT program on track to deliver $55 million in savings for 2026; program produced durable P&L benefits that began in Q4 2025 and continued in Q1 2026.
Labor and Contract Labor Improvements
Salaries, wages, and benefits expense per adjusted admission decreased 1.4% in Q1. Contract labor expense was reduced by over 40% to $15 million, with contract labor as a percent of SW&B improving from 3.8% (Q1 2025) to 2.2% (Q1 2026), a ~160 basis-point y/y improvement.
Supply Chain and Cost Controls
Supply expense per adjusted admission grew modestly at 1.7% while supply expense as a percent of revenue improved 50 basis points year-over-year, driven by vendor consolidation, renegotiated distribution contracts, and improved rebates.
Balance Sheet and Liquidity Strength
Ended Q1 with $610 million cash, $1.1 billion total debt, and $0.9 billion available liquidity. Total net leverage was 1.0x and lease-adjusted net leverage improved to 2.6x from 3.0x in Q1 2025.
Ambulatory and Access Expansion
Opened four urgent care centers (Texas, New Mexico, Idaho) in Q1 and plans for the rest of 2026 include 2 ASCs, 1 freestanding ED, and 1 urgent care to drive incremental volume and higher-margin growth.
Technology and Care Transformation Initiatives
Announced enterprise-wide AI-assisted virtual care partnership with hellocare.ai across 2,000+ patient rooms; virtual patient monitoring is already live and expected to support patient safety and labor efficiency as deployment completes by year-end.
Operational Metrics and Seasonality Management
Improved precision staffing led to Q1 SW&B growth of only 0.6% in the context of IMPACT; company successfully mitigated impacts from severe winter storms and a light flu season by rescheduling surgeries and adjusting labor.
ARDT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ARDT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | $10.13 | $9.37 | -7.50% |
Mar 04, 2026 | $9.64 | $9.44 | -2.07% |
Nov 12, 2025 | $14.05 | $9.30 | -33.81% |
Aug 05, 2025 | $10.65 | $11.30 | +6.10% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ardent Health Partners, Inc. (ARDT) report earnings?
Ardent Health Partners, Inc. (ARDT) is schdueled to report earning on Aug 19, 2026, After Close (Confirmed).
What is Ardent Health Partners, Inc. (ARDT) earnings time?
Ardent Health Partners, Inc. (ARDT) earnings time is at Aug 19, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ARDT EPS forecast?
ARDT EPS forecast for the fiscal quarter 2026 (Q2) is 0.25.